Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4-CD8-Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus

被引:125
|
作者
Kato, Hiroshi
Perl, Andras
机构
[1] SUNY Upstate Med Univ, Coll Med, Dept Med, Div Rheumatol, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Univ, Coll Med, Dept Microbiol & Immunol, Div Rheumatol, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Coll Med, Dept Biochem & Mol Biol, Div Rheumatol, Syracuse, NY 13210 USA
基金
美国国家卫生研究院;
关键词
ROR-GAMMA-T; MAMMALIAN TARGET; DISEASE-ACTIVITY; DECREASED PRODUCTION; INTERFERON-GAMMA; HELPER-CELLS; MTOR KINASE; TGF-BETA; IN-VIVO; DIFFERENTIATION;
D O I
10.4049/jimmunol.1301859
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanistic target of rapamycin (mTOR) is activated in CD4-CD8-double-negative (DN) T cells and its blockade is therapeutic in systemic lupus erythematosus (SLE) patients. Murine studies showed the involvement of mTOR complex 1 (mTORC1) and 2 (mTORC2) in the differentiation of Th1/Th17 cells and Th2 cells, respectively. In this study, we investigated the roles of mTORC1 and mTORC2 in T cell lineage development in SLE and matched healthy control (HC) subjects. mTORC1 activity was increased, whereas mTORC2 was reduced, as assessed by phosphorylation of their substrates phosphorylated S6 kinase 1 or phosphorylated S6 ribosomal protein and phosphorylated Akt, respectively. Rapamycin inhibited mTORC1 and enhanced mTORC2. IL-4 expression was increased in freshly isolated CD8(+) lupus T cells (SLE: 8.09 +/- 1.93%, HC: 3.61 +/- 0.49%; p = 0.01). DN T cells had greater IL-4 expression than CD4(+) or CD8(+) T cells of SLE patients after 3-d in vitro stimulation, which was suppressed by rapamycin (control: 9.26 +/- 1.48%, rapamycin: 5.03 +/- 0.66%; p < 0.001). GATA-3 expression was increased in CD8(+) lupus T cells (p < 0.01) and was insensitive to rapamycin treatment. IFN-gamma expression was reduced in all lupus T cell subsets (p = 1.0 x 10(-5)) and also resisted rapamycin. IL-17 expression was increased in CD4(+) lupus T cells (SLE: 3.62 +/- 0.66%, HC: 2.29 +/- 0.27%; p = 0.019), which was suppressed by rapamycin (control: 3.91 +/- 0.79%, rapamycin: 2.22 +/- 0.60%; p < 0.001). Frequency of regulatory T cells (Tregs) was reduced in SLE (SLE: 1.83 +/- 0.25%, HC: 2.97 +/- 0.27%; p = 0.0012). Rapamycin inhibited mTORC1 in Tregs and promoted their expansion. Neutralization of IL-17, but not IL-4, also expanded Tregs in SLE and HC subjects. These results indicate that mTORC1 expands IL-4(+) DN T and Th17 cells, and contracts Tregs in SLE. The Journal of Immunology, 2014, 192: 4134-4144.
引用
收藏
页码:4134 / 4144
页数:11
相关论文
共 50 条
  • [31] Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells
    Gallon, Lorenzo
    Traitanon, Opas
    Yu, Yuming
    Shi, Bo
    Leventhal, Joseph R.
    Miller, Joshua
    Mas, Valeria
    Xu, L.
    Mathew, James M.
    TRANSPLANTATION, 2015, 99 (09) : 1774 - 1784
  • [32] Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus
    Xiang, Nan
    Fang, Xuan
    Sun, Xiao-Ge
    Zhou, Ying-Bo
    Ma, Yan
    Zhu, Chen
    Li, Xiang-Pei
    Wang, Guo-sheng
    Tao, Jin-hui
    Li, Xiao-Mei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (04) : 621 - 632
  • [33] Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T Cells
    Rieder, Sadiye Amcaoglu
    Metidji, Amina
    Glass, Deborah Dacek
    Thornton, Angela M.
    Ikeda, Tohru
    Morgan, Bruce A.
    Shevach, Ethan M.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (02) : 553 - 563
  • [34] The effects of Th9, Th17, CD4+CD25+FoxP3+regulatory T cells in adult primary immune thrombocytopenia
    Gao, Y.
    Zhou, S.
    Chen, M.
    Shao, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 423 - 423
  • [35] Generation of IL-8 and IL-9 Producing CD4+ T Cells Is Affected by Th17 Polarizing Conditions and AHR Ligands
    Gasch, Michaela
    Goroll, Tina
    Bauer, Mario
    Hinz, Denise
    Schuetze, Nicole
    Polte, Tobias
    Kesper, Doerthe
    Simon, Jan C.
    Hackermueller, Joerg
    Lehmann, Irina
    Herberth, Gunda
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [36] Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells
    Rojas, Ingrid M. Leal
    Mok, Wai-Hong
    Pearson, Frances E.
    Minoda, Yoshihito
    Kenna, Tony J.
    Barnard, Ross T.
    Radford, Kristen J.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [37] Co-Culture of Human Bronchial Fibroblasts and CD4+T Cells Increases Th17 Cytokine Signature
    Loubaki, Lionel
    Hadj-Salem, Ikhlass
    Fakhfakh, Raouia
    Jacques, Eric
    Plante, Sophie
    Boisvert, Marc
    Aoudjit, Fawzi
    Chakir, Jamila
    PLOS ONE, 2013, 8 (12):
  • [38] Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance
    Xiang, Mingli
    Guo, Li
    Ma, Yan
    Li, Yi
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 619 - 624
  • [39] Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance
    Xiang, Mingli
    Guo, Li
    Ma, Yan
    Li, Yi
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (06) : 2405 - 2410
  • [40] CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?
    Mesquita, D., Jr.
    Mastroianni Kirsztajn, G.
    Franco, M. F.
    Reis, L. A.
    Perazzio, S. F.
    Mesquita, F. V.
    da Silva Ferreira, V.
    Coelho Andrade, L. E.
    Silva de Souza, A. W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01) : 50 - 59